Literature DB >> 6293575

Inhibition of protein synthesis by a tryptic polypeptide of Clostridium perfringens type A enterotoxin.

P E Granum.   

Abstract

The biological activity of Clostridium perfringens enterotoxin can be tested more precisely and with a much higher sensitivity by using the inhibition of protein synthesis by Vero cells, rather than the guinea pig skin test. Tryptic peptides of the enterotoxin produced in the presence of different concentrations of sodium dodecyl sulfate (0-1%) have been tested for biological activity (Vero cells) and inhibitory effect on cell-free protein synthesis (rabbit reticulocyte lysate). A fraction of tryptic peptides, about 16,000 daltons, was able to inhibit the cell-free protein synthesis, while the native enterotoxin had no such effect. The 16 kDa fraction had, however, lost the ability to disrupt the Vero cells (normal biological activity). It is probable that the enterotoxin has the double function (A and B chain), known from several other toxins, confined in its single polypeptide chain.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6293575     DOI: 10.1016/0167-4838(82)90196-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Mapping of functional regions of Clostridium perfringens type A enterotoxin.

Authors:  P C Hanna; E U Wieckowski; T A Mietzner; B A McClane
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

2.  Isolation and function of a Clostridium perfringens enterotoxin fragment.

Authors:  Y Horiguchi; T Akai; G Sakaguchi
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

3.  Characterization of a parasporal inclusion body from sporulating, enterotoxin-positive Clostridium perfringens type A.

Authors:  A Löffler; R Labbé
Journal:  J Bacteriol       Date:  1986-02       Impact factor: 3.490

4.  Preliminary evidence that Clostridium perfringens type A enterotoxin is present in a 160,000-Mr complex in mammalian membranes.

Authors:  A P Wnek; B A McClane
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

5.  Sequence of the amino-terminal part of enterotoxin from Clostridium perfringens type A: identification of points of trypsin activation.

Authors:  M Richardson; P E Granum
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

6.  Production and characterization of monoclonal antibodies to Clostridium perfringens enterotoxin.

Authors:  Y Horiguchi; T Uemura; Y Kamata; S Kozaki; G Sakaguchi
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.